AVN-342

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAVN-342
Drug Alias NameCB1 receptor modulators (Azevan)AVN-342
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor modulators
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsSubstance-Related DisordersObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAzevan Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAzevan Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSubstance-Related DisordersObesity

Other Information

ATC CodeN/A
Related LinksN/A